-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Testosterone therapy can increase bone mineral density (BMD) in men with hypogonadism.
The researchers recruited men over the age of 50 from six research centers in Australia.
The primary endpoint of the study was cortical volumetric BMD (vBMD) of the distal tibia, measured by HR-pQCT in 177 men (one center).
Compared with placebo, within 24 months, testosterone treatment increased tibial cortex vBMD, 9.
It can be seen that for men over 50 years of age, testosterone treatment for 2 years mainly affects the cortical bone and increases bone density.
For men over 50, testosterone treatment for 2 years mainly affects the cortical bone and increases bone density.
Original source:
Mark Ng Tang Fui.
ncbi.
nlm.
nih.
gov/33693907/" target="_blank" rel="noopener">Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT in this message